from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0211/pckA

LFCtreatmentdescriptionclass of inhibitor

0.643

Amikacinug/mL Amikacintranslation

0.643

Cap5-10ug/mL Capreomycintranslation

1.548

Rox10-50 ug/mL Roxithromycintranslation

1.013

SM2-5 ug/mL Streptomycintranslation

0.496

Tet5-10 ug/mL Tetracyclinetranslation

-1.252

Rif0.2-5ug/mL Rifampicintranscription

-0.739

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.912

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.085

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.633

CPZ10-50 ug/mL Chlorpromazinerespiration

1.684

Clofazimine10-13 ug/mL Clofaziminerespiration

0.511

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.724

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.143

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.685

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.817

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.672

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.799

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.648

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.046

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.503

KCN5-20 ug/mL Potassium cyaniderespiration

2.257

NaN30.2-2 mM Sodium aziderespiration

1.158

Nigericin50 uM Nigericinrespiration

0.186

TRC10-150 ug/mL Triclosanrespiration

-0.537

TRZ10-25 ug/mL Thioridazinerespiration

1.408

Valinomycin0.5-10 uM Valinomycinrespiration

-0.650

ZnSO42 mM ZnSO4respiration

1.368

menadione6-10 ug/mL Menadionerespiration

0.021

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.595

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.150

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.903

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.867

NRP_1Non-replicating persistence stage 1dosRassociated

-0.409

Amp0.2mg/mL AmpicillincellWall

-0.801

Cephalexin20-100 ug/mL CephalexincellWall

0.557

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.912

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.366

EMB10-20 ug/mL EthambutolcellWall

1.022

Eta12-40 ug/mL EthionamidecellWall

0.870

INH0.2-0.4 ug/mL IsoniazidcellWall

0.311

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.347

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.424

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.693

BZA0.12 mg/mL BenzamidearomaticAmides

-0.678

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.515

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.340

H2O24 mM hydrogen peroxideDNAdamaging

-0.161

Levo10 ug/mL LevofloxacinDNAdamaging

-0.641

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.183

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.026

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.721

UVUV-irradiationDNAdamaging

-0.166

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.906

Antimycin12.5-50 ug/mL Antimycin A?

-0.724

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.011

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.057

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.761

PA8240.2-2 ug/mL PA-824?

1.019

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.750

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.929

Verapamil50 uM Verapamil?

-0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.572

methoxatin10-20 ug/mL Methoxatin?